HEMMUNG DER TNF - BILDUNG
PCT No. PCT/GB93/02331 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/10990 PCT Pub. Date May 26, 1994The present invention is directed to the method of inhibiting the release of tumor necrosis factor (TNF) in a condition mediated by TNF by adminis...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CRIMMIN, MICHAEL JOHN GEARING, ANDREW JOHN HUBERT GALLOWAY, WILLIAM ALAN |
| description | PCT No. PCT/GB93/02331 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/10990 PCT Pub. Date May 26, 1994The present invention is directed to the method of inhibiting the release of tumor necrosis factor (TNF) in a condition mediated by TNF by administration of certain hydroxamic add derivatives, also known as matrix metalloproteinase inhibitors, and thus the method of this invention is useful in the management of diseases or conditions mediated by TNF. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE150300TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE150300TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE150300TT13</originalsourceid><addsrcrecordid>eNrjZJD0cPX1DfVzV3BxDVII8XNT0FVw8vRxAYrwMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4xxBXQ1MDYwODkBBDY2LUAADxoh_6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HEMMUNG DER TNF - BILDUNG</title><source>esp@cenet</source><creator>CRIMMIN, MICHAEL JOHN ; GEARING, ANDREW JOHN HUBERT ; GALLOWAY, WILLIAM ALAN</creator><creatorcontrib>CRIMMIN, MICHAEL JOHN ; GEARING, ANDREW JOHN HUBERT ; GALLOWAY, WILLIAM ALAN</creatorcontrib><description>PCT No. PCT/GB93/02331 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/10990 PCT Pub. Date May 26, 1994The present invention is directed to the method of inhibiting the release of tumor necrosis factor (TNF) in a condition mediated by TNF by administration of certain hydroxamic add derivatives, also known as matrix metalloproteinase inhibitors, and thus the method of this invention is useful in the management of diseases or conditions mediated by TNF.</description><edition>6</edition><language>ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970415&DB=EPODOC&CC=AT&NR=E150300T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970415&DB=EPODOC&CC=AT&NR=E150300T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CRIMMIN, MICHAEL JOHN</creatorcontrib><creatorcontrib>GEARING, ANDREW JOHN HUBERT</creatorcontrib><creatorcontrib>GALLOWAY, WILLIAM ALAN</creatorcontrib><title>HEMMUNG DER TNF - BILDUNG</title><description>PCT No. PCT/GB93/02331 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/10990 PCT Pub. Date May 26, 1994The present invention is directed to the method of inhibiting the release of tumor necrosis factor (TNF) in a condition mediated by TNF by administration of certain hydroxamic add derivatives, also known as matrix metalloproteinase inhibitors, and thus the method of this invention is useful in the management of diseases or conditions mediated by TNF.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD0cPX1DfVzV3BxDVII8XNT0FVw8vRxAYrwMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4xxBXQ1MDYwODkBBDY2LUAADxoh_6</recordid><startdate>19970415</startdate><enddate>19970415</enddate><creator>CRIMMIN, MICHAEL JOHN</creator><creator>GEARING, ANDREW JOHN HUBERT</creator><creator>GALLOWAY, WILLIAM ALAN</creator><scope>EVB</scope></search><sort><creationdate>19970415</creationdate><title>HEMMUNG DER TNF - BILDUNG</title><author>CRIMMIN, MICHAEL JOHN ; GEARING, ANDREW JOHN HUBERT ; GALLOWAY, WILLIAM ALAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE150300TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1997</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CRIMMIN, MICHAEL JOHN</creatorcontrib><creatorcontrib>GEARING, ANDREW JOHN HUBERT</creatorcontrib><creatorcontrib>GALLOWAY, WILLIAM ALAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CRIMMIN, MICHAEL JOHN</au><au>GEARING, ANDREW JOHN HUBERT</au><au>GALLOWAY, WILLIAM ALAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HEMMUNG DER TNF - BILDUNG</title><date>1997-04-15</date><risdate>1997</risdate><abstract>PCT No. PCT/GB93/02331 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Nov. 12, 1993 PCT Pub. No. WO94/10990 PCT Pub. Date May 26, 1994The present invention is directed to the method of inhibiting the release of tumor necrosis factor (TNF) in a condition mediated by TNF by administration of certain hydroxamic add derivatives, also known as matrix metalloproteinase inhibitors, and thus the method of this invention is useful in the management of diseases or conditions mediated by TNF.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_ATE150300TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HEMMUNG DER TNF - BILDUNG |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A10%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CRIMMIN,%20MICHAEL%20JOHN&rft.date=1997-04-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE150300TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |